Skip to content
Mind Medicine (MindMed) Inc. episode artwork

Jun 16, 2020 17 min

Mind Medicine (MindMed) Inc.

from OTCQB Podcast Hosted by OTC Markets Group

Mind Medicine (MindMed) Inc. (OTCQB: MMEDF) is a neuro-pharmaceutical company that discovers, develops, and deploys psychedelic inspired medicines to offer solutions to address mental health issues including anxiety, addiction, and depression. CEO, JR Rahn, provides a perspective on how the current social and economic climate correlates with mental health and Mind Med's mission to provide therapeutic benefits of psychedelics to resolve mental illness.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Mind Medicine (MindMed) Inc.

0:00 17:54

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 17 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on June 16, 2020.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.